A Study to Evaluate the Efficacy and Safety of CAM-3001 (Drug) in Subjects With Rheumatoid Arthritis
Status:
Completed
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
To assess the safety, tolerability and efficacy of multiple doses of the drug, CAM-3001
administered in patients with moderately active Rheumatoid Arthritis.